709
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Article

Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, northwest China: A large - scale cross-sectional study

, , , , , , , & show all
Article: 2133913 | Received 19 Jul 2022, Accepted 06 Oct 2022, Published online: 18 Oct 2022

References

  • Jakinovich A, Sood SK. Pertussis: still a cause of death, seven decades into vaccination. Curr Opin Pediatr. 2014;26(5):1–8. doi:10.1097/MOP.0000000000000139.
  • Zamir CS, Dahan DB, Shoob H. Pertussis in infants under one year old: risk markers and vaccination status–a case-control study. Vaccine. 2015;33(17):2073–78. doi:10.1016/j.vaccine.2015.02.050.
  • Organization WH. Pertussis global annual reported cases and DTP3 coverage, 1980-2015.
  • Cherry JD. Epidemic pertussis in 2012–the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785–87. doi:10.1056/NEJMp1209051.
  • World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(40):385–400.
  • Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis. 2012;205(8):1220–24. doi:10.1093/infdis/jis178.
  • Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill. 2013;18(38):20587.
  • Winter K, Glaser C, Watt J, Harriman K. Pertussis epidemic–California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1129–32.
  • Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82. doi:10.1128/CMR.18.2.326-382.2005.
  • Castagnini LA, Munoz FM. Clinical characteristics and outcomes of neonatal pertussis: a comparative study. J Pediatr. 2010;156(3):498–500. doi:10.1016/j.jpeds.2009.10.013.
  • Nooitgedagt JE, de Greeff SC, Elvers BH, de Melker HE, Notermans DW, van Huisseling H, Versteegh F. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin. Clin Infect Dis. 2009;49(7):1086–89. doi:10.1086/605575.
  • Guimaraes LM, Carneiro EL, Carvalho-Costa FA. Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data. BMC Infect Dis. 2015;15(1):442. doi:10.1186/s12879-015-1222-3.
  • Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis. 2014;209(7):978–81. doi:10.1093/infdis/jiu001.
  • Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, Ladhani S. Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed. 2017;102(5):F456–F63. doi:10.1136/archdischild-2016-312341.
  • Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J. 2005;24(5):S10–8. doi:10.1097/01.inf.0000160708.43944.99.
  • Lartigue MF, Monnet X, Le Flèche A, Grimont PA, Benet JJ, Durrbach A, Fabre M, Nordmann P. Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol. 2005;43(2):999–1001. doi:10.1128/JCM.43.2.999-1001.2005.
  • Tiwari TS, Golaz A, Yu DT, Ehresmann KR, Jones TF, Hill HE, Cassiday PK, Pawloski LC, Moran JS, Popovic T. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis. 2008;46(3):395–401. doi:10.1086/525262.
  • Dureab F, Al-Sakkaf M, Ismail O, Kuunibe N, Krisam J, Müller O, Jahn A. Diphtheria outbreak in Yemen: the impact of conflict on a fragile health system. Confl Health. 2019;13(1):19. doi:10.1186/s13031-019-0204-2.
  • Sharma NC, Efstratiou A, Mokrousov I, Mutreja A, Das B, Ramamurthy T. Diphtheria. Nat Rev Dis Primers. 2019;5(1):81. doi:10.1038/s41572-019-0131-y.
  • Forsyth KD, Campins-Marti M, Caro J, Cherry JD, Greenberg D, Guiso N, Heininger U, Schellekens J, Tan T, von Konig Carl-Heinz W. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis. 2004;39(12):1802–09. doi:10.1086/426020.
  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5):S58–61. doi:10.1097/01.inf.0000160914.59160.41.
  • Hodder SL, Cherry JD, Mortimer EA Jr., Ford AB, Gornbein J, Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis. 2000;31(1):7–14. doi:10.1086/313913.
  • Zhang Q, Han F, Nie Q, Ren H, Zhang B, Liu Q, He Q, Shao Z. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect. 2011;63(6):441–46. doi:10.1016/j.jinf.2011.07.018.
  • Chen Z, Zhang J, Cao L, Zhang N, Zhu J, Ping G, Zhao J, Li S, He Q. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years. J Infect. 2016;73(1):38–44. doi:10.1016/j.jinf.2016.04.004.
  • Zhang Y, Chen Z, Zhao J, Zhang N, Chen N, Zhang J. Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010-2016. J Infect. 2019;79(1):1–6. doi:10.1016/j.jinf.2019.04.011.
  • He H, Yao P, Zhou Y, Deng X, Pan J, Hozbor DF. Is pertussis infection neglected in China? Evidence from a seroepidemiology survey in Zhejiang, an Eastern Province of China. PLoS One. 2016;11(5):e0155965. doi:10.1371/journal.pone.0155965.
  • Liu D, Cheng X, Wei S, Yuan L, Chen C, Yao K. Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China. Hum Vaccin Immunother. 2021;17(6):1757–62. doi:10.1080/21645515.2020.1840253.
  • Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13(1):146. doi:10.1186/s12916-015-0382-8.
  • Li X, Chen M, Zhang T, Li J, Zeng Y, Lu L. Seroepidemiology of diphtheria and pertussis in Beijing, China: a cross-sectional study. Hum Vaccin Immunother. 2015;11(10):2434–39. doi:10.1080/21645515.2015.1062954.
  • Zhang J, Xie X. Epidemiological characteristics for reported cases of pertussis from 2009 to 2019 in Tai’an City. Prog in Microbiol Immunol. 2021;49:68–72. doi:10.1111/j.1574-695X.2006.00174.x.
  • Vaz-de-lima LRA, Sato HK, Fernandes EG, Sato APS, Pawloski LC, Tondella ML, de Brito CA, Luna EJA, Carvalhanas TRMP, de Castilho EA, et al. Association between the timing of maternal vaccination and newborns’ anti-pertussis toxin antibody levels. Vaccine. 2019;37(36):5474–80. doi:10.1016/j.vaccine.2019.04.079.
  • Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(5):136–38. doi:10.15585/mmwr.mm6605e2.
  • Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB, Woods L, Wilson A . Recommended immunization schedule for adults aged 19 years or older, United States, 2017. Ann Intern Med. 2017;166(3):209–19. doi:10.7326/M16-2936.
  • Clark TA, Bobo N. CDC update on pertussis surveillance and Tdap vaccine recommendations. NASN Sch Nurse. 2012;27(6):297–300. doi:10.1177/1942602X12452443.
  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi A, Damme P, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11(7):557–70. doi:10.1016/S1473-3099(11)70007-X.
  • Meng QH, Liu Y, Yu JQ, Li LJ, Shi W, Shen YJ, Li L, Zhan SN, Yang F, Wang YJ, et al. Seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps and rubella in Shunyi, Beijing. Sci Rep. 2018;8(1):13021. doi:10.1038/s41598-018-31283-y.
  • Chen Z, Pang J, Zhang N, Chen N, Ding Y, He Q. Seroprevalence study of pertussis in adults at childbearing age and young infants reveals the necessity of booster immunizations in adults in China. Vaccines (Basel). 2022;10(1): 84 .
  • Ning G, Gao Y, Wu D, Li J, Li Y, Shao Z, Yin Z . Epidemiology of pertussis in China, 2011-2017. Chin J Vaccines Immunization. 2018;24:264–7+73.
  • Gordon M, Davies HD, Gold R. Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. Pediatr Infect Dis J. 1994;13(7):617–22. doi:10.1097/00006454-199407000-00007.
  • Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J. 2009;28(7):582–87. doi:10.1097/INF.0b013e318197fac1.
  • Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29(3):449–86. doi:10.1128/CMR.00083-15.
  • Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet. 1985;1(8434):900–02. doi:10.1016/S0140-6736(85)91675-7.
  • Liang L, Ma Y, Wei J, Deng L, Wei Y, Zhong G, Liu W. Antibody levels against diphtheria among a healthy population in Guangxi Zhuang autonomous region, 2013. Chin J Vaccines Immunization. 2016;22:175–79.
  • Yao N, Zeng Q, Wang Q. Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection. Public Health. 2018;156:60–66. doi:10.1016/j.puhe.2017.12.009.
  • Polonsky JA, Ivey M, Mazhar MKA, Rahman Z, le Polain de Waroux O, Karo B, Jalava K, Vong S, Baidjoe A, Diaz J, et al. Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox’s Bazar, Bangladesh, 2017 to 2019: a retrospective study. PLoS Med. 2021;18(4):e1003587. doi:10.1371/journal.pmed.1003587.
  • Zhu Q, Liu M, Wu C, Tan Q, Shao X, Xu X, Zheng H. Diphtheria antibody levels in selected regions of Guangdong province, 2014. Chin J Vaccines Immunization. 2016;22:267–70.
  • Geng S, Zhao M, Guo S, Zhang D, Xia H, Wan S, Cong K, Zheng H. Diphtheria antibody levels and sero-prevalence among healthy people of Xuchang city in 2020. Chin J Vaccines Immunization. 2021;27:537–39.
  • Chen Z, Zhang H, Wang Q, Zhang S, Li D, Yang X, Zhou Y, Zheng K. Diphtheria antibody levels among a community-dwelling population aged 0-61 years in Fujian province, 2018. Chin J Vaccines Immunization. 2020;26:521–24.